Literature DB >> 33009325

Prognostic Factors for Orbital Exenteration, Local Recurrence, Metastasis, and Death From Disease in Conjunctival Squamous Cell Carcinoma.

Christian El-Hadad1, Maria Laura Rubin2, Priya Nagarajan3, Joshua Richard Ford1, Shiqiong Xu1, Jing Ning2, Bita Esmaeli1.   

Abstract

PURPOSE: Information regarding risk of metastasis and disease-related death (DD) from conjunctival squamous cell carcinoma (SCC) is relatively scarce. We explored prognostic factors for orbital exenteration, local recurrence, nodal metastasis, and DD in patients with conjunctival SCC.
DESIGN: Retrospective cross-sectional study.
METHODS: All consecutive patients with conjunctival SCC treated by the senior author at MD Anderson Cancer Center during1999-2018 were included. Survival curves were estimated using the Kaplan-Meier method, and survival differences were assessed using 2-sided log-rank tests.
RESULTS: The study included 44 patients (24 men, 20 women); median age was 64 years (range, 40-90). T categories at presentation were as follows: Tis, 20 patients; T2, 8; T3, 9; and T4, 7. Eighteen patients (41%) had tumors exclusively in the bulbar conjunctiva; 26(59%) had nonbulbar conjunctival involvement. The median follow-up time was 29.2 months (95% CI: 21.8-44.3). Orbital exenteration was performed in 10 cases (23%) and was associated with T3 or more advanced disease at presentation (p < 0.001). Seven patients developed local recurrence during follow up. History of organ transplant correlated with local recurrence and orbital exenteration (p < 0.01). Nodal metastasis was present in 1 patient at presentation and occurred in 3 patients during follow up, for an overall nodal metastasis rate of 9% (4/44). By end of follow up, 2 patients had died of disease, 4 had died of other causes, and 38 were alive with no evidence of disease. The results suggest that both orbital exenteration and nodal metastasis are independent variables associated with DD.
CONCLUSIONS: In patients with conjunctival SCC, orbital exenteration and nodal metastasis are associated with DD and organ transplantation is associated with orbital exenteration.
Copyright © 2021 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33009325      PMCID: PMC7865015          DOI: 10.1097/IOP.0000000000001798

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   2.011


  18 in total

1.  Conjunctival and corneal intraepithelial and invasive neoplasia.

Authors:  J C Erie; R J Campbell; T J Liesegang
Journal:  Ophthalmology       Date:  1986-02       Impact factor: 12.079

2.  Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.

Authors:  Yacoub A Yousef; Paul T Finger
Journal:  Ophthalmology       Date:  2011-12-20       Impact factor: 12.079

3.  Conjunctival squamous cell carcinoma arising in immunosuppressed patients (organ transplant, human immunodeficiency virus infection).

Authors:  Carol L Shields; Aparna Ramasubramanian; Phoebe L Mellen; Jerry A Shields
Journal:  Ophthalmology       Date:  2011-07-16       Impact factor: 12.079

4.  Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.

Authors:  Anat Galor; Carol L Karp; Patrick Oellers; Andrew A Kao; Amany Abdelaziz; William Feuer; Sander R Dubovy
Journal:  Ophthalmology       Date:  2012-06-14       Impact factor: 12.079

5.  Conjunctival squamous cell carcinoma: prognostic factors for the recurrence and metastasis and clinicopathological characteristics at an oncological hospital in Peru.

Authors:  Deivy Cruzado-Sanchez; Walter Andree Tellez; Beltran Villarreal-Aguilar; Monica Melendez; Anibal Olivera; Fiorella Moran; Solon Serpas-Frias; Raul Cordero-Garcia
Journal:  Br J Ophthalmol       Date:  2019-10-11       Impact factor: 4.638

6.  Squamous cell carcinoma of the conjunctiva: clinicopathological features in 287 cases.

Authors:  Guadalupe Cervantes; Abelardo A Rodríguez; Alfredo Gómez Leal
Journal:  Can J Ophthalmol       Date:  2002-02       Impact factor: 1.882

7.  Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture.

Authors:  Carol L Shields; Adel E Alset; Nina S Boal; Mairghread G Casey; Austen N Knapp; Jordan A Sugarman; Marisa A Schoen; Phillip S Gordon; Alexzandra M Douglass; Kareem Sioufi; Emil A T Say; Jerry A Shields
Journal:  Am J Ophthalmol       Date:  2016-10-08       Impact factor: 5.258

8.  Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.

Authors:  Sanket U Shah; Swathi Kaliki; H Jane Kim; Sara E Lally; Jerry A Shields; Carol L Shields
Journal:  Arch Ophthalmol       Date:  2012-02

9.  Conjunctival Squamous Neoplasia: Staging and Initial Treatment.

Authors:  Claudine Bellerive; Jesse L Berry; Ashley Polski; Arun D Singh
Journal:  Cornea       Date:  2018-10       Impact factor: 2.651

Review 10.  Epidemiology of ocular surface squamous neoplasia in Africa.

Authors:  Stephen Gichuhi; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  Trop Med Int Health       Date:  2013-10-30       Impact factor: 2.622

View more
  2 in total

1.  Identification of Metastatic Conjunctival Squamous Cell Carcinoma through Neck Palpation.

Authors:  Thamanna Nishath; Minh T Nguyen; Michael Wu; Desiree A Marshall; Andrew W Stacey
Journal:  Case Rep Ophthalmol       Date:  2022-06-07

2.  Modified procedure of anterior orbital exenteration enables eye socket reconstruction: A retrospective cohort study.

Authors:  Ruiqi Ma; Xiaofeng Li; Lu Gan; Jie Guo; Jiang Qian
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.